C2i Genomics deploys an innovative ctDNA MRD solution for personalized cancer detection and monitoring. C2i’s whole-genome technology provides ultra-high sensitivity with significantly reduced lab operation complexity, eliminate the need to develop a patient-specific assay, and allowing earlier detection of recurrent cancer, to inform better treatment decisions and improve outcomes.
Additional Info
- Banner Image URL: images/Sponsor/c2i_genomics.gif
- Website URL: https://c2i-genomics.com
Published in
Bronze Sponsor
Latest from Dave Venus
Leave a comment
Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.
